Skip to content

Treatment for Children with Childhood Apraxia of Speech

Will children with Childhood Apraxia of Speech benefit from the Kaufman Speech to Language Protocol to improve speech outcomes.

Status
Suspended
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12615000695505
Enrollment
6
Registered
2015-07-03
Start date
2015-07-16
Completion date
2015-11-18
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The aim of this study is to explore the effectiveness of Kaufman Speech to Language Protocol in improving the accuracy of words in children with CAS. The hypothesis is that the implementation of the K-SLP approach for CAS will result in more accurate speech production in target words than no treatment.

Interventions

This research will use a single case experimental design with multiple baselines across behaviours and participants. Each child will participate in initial baseline data collection, 3 weeks of individualized and targeted one-on-one treatment using the Kaufman Speech to Language protocol (K-SLP), followed by post treatment maintenance follow up. Initial baselines will comprise of between 3-5 data points randomly assigned to participants to allow for stability in measurement and to determine any c

This research will use a single case experimental design with multiple baselines across behaviours and participants. Each child will participate in initial baseline data collection, 3 weeks of individualized and targeted one-on-one treatment using the Kaufman Speech to Language protocol (K-SLP), followed by post treatment maintenance follow up. Initial baselines will comprise of between 3-5 data points randomly assigned to participants to allow for stability in measurement and to determine any clear visual trends before commencement of treatment, and to ensure stable speech production. The data to be collected includes the participant’s production of a predetermined and individualised set of words: including treated words (words that are used during the treatment session), control words (words that are untreated and do not have the same features as treatment words) and foil words (have similar features as the treated words but are untreated). This phase will be conducted in the clinic. Treatment phase: During the treatment phase, a trained clinician (speech pathologist/trained speech pathology student) will administer treatment as per the K-SLP protocol in the clinic for 60 minutes per day 4 times/week for 3 weeks. Treatment will consist of 20 preselected treatment words. The selection of these words will be based on the chosen sounds or word features that will be the target of the treatment for each client. This will be determined based on the initial pre-test diagnostic assessments. Additionally there will be untreated words- 20 foil words, 20 control words that will have similar features or sounds as the treatment words. Additional data points will be collected every 4th treatment session using the predetermined individualised word lists comprised of words that are part of the participant’s treatment set, and words that are not treated. Final post-treatment assessments will be conducted at 1-week post treatment, 2 weeks and 3 months post treatment.

Sponsors

Mirjana Gomez
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
3 Years to 5 Years
Healthy volunteers
No

Inclusion criteria

Diagnosis of Childhood Apraxia of Speech 3-5 years of age Normal vision (adjusted to normal eg. wears glasses) Normal hearing acuity Child must speak English as primary language. One parent speaks English as their primary language.

Exclusion criteria

Autism Spectrum Disorder Known neurological deficits Intellectual impairment Structural/oral motor anomalies

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026